Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and efficacy (% response) of epoetin
alfa in the treatment of anemia in adults receiving chemotherapy for cancer.